Back to Test Catalogue

Heparin – Fondaparinux, Plasma

Test ID: HEPFONDA
Test
Specimen
Performance / Interpretation
Interface / Setup

Test

Aliases/Synonyms

Arixtra

Method

Chromogenic

Platform

STA-R Analyzer

Report Includes

Heparin - Fondaparinux

Specimens

Plasma (Na Citrate)

Test Location

Laboratory Reference Centre, 237 Barton Street E, Hamilton ON L8L 2X2

Test Version

8-Jun-2023

Specimen

Specimens

Plasma (Na Citrate)

Sample Volume

1 mL

Collection & Handling

Handling Information

Prepare platelet poor plasma. Separate and freeze immediately. Store and send frozen.

Rejection Criteria

Specimen Not frozen

Test Version

8-Jun-2023

Performance / Interpretation

Method

Chromogenic

Platform

STA-R Analyzer

Turnaround Time

3 days

Results

Name Units Reference Range Conversion Factor
Heparin - Fondaparinux U/mL
  • A therapeutic range for Fondaparinux has not been established. Average peak, steady-state levels (2 - 3 hours post-dose) of approximately 1.02-1.07 IU anti-Xa activity/mL have been reported for patients given therapeutic doses of Fondaparinux for symptomatic DVT/PE.

Test Location

Laboratory Reference Centre, 237 Barton Street E, Hamilton ON L8L 2X2

Test Version

8-Jun-2023

Interface / Setup

HL7 Interface Codes

Order Code Result Codes Units
HEPFONA 28134HEP 10A - FONDA U/mL

Test Version

8-Jun-2023